Klotho suppresses the renin-angiotensin system in adriamycin nephropathy

Tsuneo Takenaka, Tsutomu Inoue, Takashi Miyazaki, Hiroyuki Kobori, Akira Nishiyama, Naohito Ishii, Matsuhiko Hayashi, Hiromichi Suzuki

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Backgrounds: Klotho protein interacts with the transforming growth factor β (TGF-β) receptor and Wnt, which contribute to the progression of renal disease, inhibiting their signals. Renal and circulating klotho levels are diminished in chronic kidney disease. Methods: Experiments were performed to assess whether supplementation of klotho protein could have protective effects on the kidney. Rats were injected with adriamycin (5 mg/kg) and divided into three groups: Those treated with vehicle, those treated with klotho protein and those treated with klotho plus 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD). Rats without adriamycin treatment were used as a control. Results: Adriamycin reduced the serum klotho concentration and renal expression of klotho and E-cadherin. Adriamycin also increased the renal expression of Wnt, TGF-β, and angiotensinogen, as well as the renal abundance of b-catenin and angiotensin II. Klotho supplementation suppressed adriamycininduced elevations of b-catenin and angiotensin II with sustained Wnt expression. Combined treatment with klotho and TDZD reversed the klotho-induced improvements in the renal abundance of b-catenin and angiotensin II as well as the expression of TGF-β and angiotensinogen without affecting Ecadherin. Conclusions: Our data indicate that Wnt is involved in the pathogenesis of adriamycin nephropathy. Furthermore, klotho supplementation inhibited Wnt signaling, ameliorating renal angiotensin II. Finally, klotho protein appears to suppress epithelial- mesenchymal transition by inhibiting TGF-β and Wnt signaling.

Original languageEnglish
Pages (from-to)791-800
Number of pages10
JournalNephrology Dialysis Transplantation
Volume32
Issue number5
DOIs
Publication statusPublished - 2017 May 1

Fingerprint

Renin-Angiotensin System
Doxorubicin
Kidney
Transforming Growth Factors
Catenins
Angiotensin II
Angiotensinogen
Epithelial-Mesenchymal Transition
Growth Factor Receptors
Cadherins
Chronic Renal Insufficiency
Disease Progression
klotho protein
Serum

Keywords

  • b-catenin
  • fibrosis
  • nephrin
  • oxidative stress
  • TRPC6

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Takenaka, T., Inoue, T., Miyazaki, T., Kobori, H., Nishiyama, A., Ishii, N., ... Suzuki, H. (2017). Klotho suppresses the renin-angiotensin system in adriamycin nephropathy. Nephrology Dialysis Transplantation, 32(5), 791-800. https://doi.org/10.1093/ndt/gfw340

Klotho suppresses the renin-angiotensin system in adriamycin nephropathy. / Takenaka, Tsuneo; Inoue, Tsutomu; Miyazaki, Takashi; Kobori, Hiroyuki; Nishiyama, Akira; Ishii, Naohito; Hayashi, Matsuhiko; Suzuki, Hiromichi.

In: Nephrology Dialysis Transplantation, Vol. 32, No. 5, 01.05.2017, p. 791-800.

Research output: Contribution to journalArticle

Takenaka, T, Inoue, T, Miyazaki, T, Kobori, H, Nishiyama, A, Ishii, N, Hayashi, M & Suzuki, H 2017, 'Klotho suppresses the renin-angiotensin system in adriamycin nephropathy', Nephrology Dialysis Transplantation, vol. 32, no. 5, pp. 791-800. https://doi.org/10.1093/ndt/gfw340
Takenaka T, Inoue T, Miyazaki T, Kobori H, Nishiyama A, Ishii N et al. Klotho suppresses the renin-angiotensin system in adriamycin nephropathy. Nephrology Dialysis Transplantation. 2017 May 1;32(5):791-800. https://doi.org/10.1093/ndt/gfw340
Takenaka, Tsuneo ; Inoue, Tsutomu ; Miyazaki, Takashi ; Kobori, Hiroyuki ; Nishiyama, Akira ; Ishii, Naohito ; Hayashi, Matsuhiko ; Suzuki, Hiromichi. / Klotho suppresses the renin-angiotensin system in adriamycin nephropathy. In: Nephrology Dialysis Transplantation. 2017 ; Vol. 32, No. 5. pp. 791-800.
@article{8da8c7e21622430e92faf5a8fb91011b,
title = "Klotho suppresses the renin-angiotensin system in adriamycin nephropathy",
abstract = "Backgrounds: Klotho protein interacts with the transforming growth factor β (TGF-β) receptor and Wnt, which contribute to the progression of renal disease, inhibiting their signals. Renal and circulating klotho levels are diminished in chronic kidney disease. Methods: Experiments were performed to assess whether supplementation of klotho protein could have protective effects on the kidney. Rats were injected with adriamycin (5 mg/kg) and divided into three groups: Those treated with vehicle, those treated with klotho protein and those treated with klotho plus 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD). Rats without adriamycin treatment were used as a control. Results: Adriamycin reduced the serum klotho concentration and renal expression of klotho and E-cadherin. Adriamycin also increased the renal expression of Wnt, TGF-β, and angiotensinogen, as well as the renal abundance of b-catenin and angiotensin II. Klotho supplementation suppressed adriamycininduced elevations of b-catenin and angiotensin II with sustained Wnt expression. Combined treatment with klotho and TDZD reversed the klotho-induced improvements in the renal abundance of b-catenin and angiotensin II as well as the expression of TGF-β and angiotensinogen without affecting Ecadherin. Conclusions: Our data indicate that Wnt is involved in the pathogenesis of adriamycin nephropathy. Furthermore, klotho supplementation inhibited Wnt signaling, ameliorating renal angiotensin II. Finally, klotho protein appears to suppress epithelial- mesenchymal transition by inhibiting TGF-β and Wnt signaling.",
keywords = "b-catenin, fibrosis, nephrin, oxidative stress, TRPC6",
author = "Tsuneo Takenaka and Tsutomu Inoue and Takashi Miyazaki and Hiroyuki Kobori and Akira Nishiyama and Naohito Ishii and Matsuhiko Hayashi and Hiromichi Suzuki",
year = "2017",
month = "5",
day = "1",
doi = "10.1093/ndt/gfw340",
language = "English",
volume = "32",
pages = "791--800",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Klotho suppresses the renin-angiotensin system in adriamycin nephropathy

AU - Takenaka, Tsuneo

AU - Inoue, Tsutomu

AU - Miyazaki, Takashi

AU - Kobori, Hiroyuki

AU - Nishiyama, Akira

AU - Ishii, Naohito

AU - Hayashi, Matsuhiko

AU - Suzuki, Hiromichi

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Backgrounds: Klotho protein interacts with the transforming growth factor β (TGF-β) receptor and Wnt, which contribute to the progression of renal disease, inhibiting their signals. Renal and circulating klotho levels are diminished in chronic kidney disease. Methods: Experiments were performed to assess whether supplementation of klotho protein could have protective effects on the kidney. Rats were injected with adriamycin (5 mg/kg) and divided into three groups: Those treated with vehicle, those treated with klotho protein and those treated with klotho plus 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD). Rats without adriamycin treatment were used as a control. Results: Adriamycin reduced the serum klotho concentration and renal expression of klotho and E-cadherin. Adriamycin also increased the renal expression of Wnt, TGF-β, and angiotensinogen, as well as the renal abundance of b-catenin and angiotensin II. Klotho supplementation suppressed adriamycininduced elevations of b-catenin and angiotensin II with sustained Wnt expression. Combined treatment with klotho and TDZD reversed the klotho-induced improvements in the renal abundance of b-catenin and angiotensin II as well as the expression of TGF-β and angiotensinogen without affecting Ecadherin. Conclusions: Our data indicate that Wnt is involved in the pathogenesis of adriamycin nephropathy. Furthermore, klotho supplementation inhibited Wnt signaling, ameliorating renal angiotensin II. Finally, klotho protein appears to suppress epithelial- mesenchymal transition by inhibiting TGF-β and Wnt signaling.

AB - Backgrounds: Klotho protein interacts with the transforming growth factor β (TGF-β) receptor and Wnt, which contribute to the progression of renal disease, inhibiting their signals. Renal and circulating klotho levels are diminished in chronic kidney disease. Methods: Experiments were performed to assess whether supplementation of klotho protein could have protective effects on the kidney. Rats were injected with adriamycin (5 mg/kg) and divided into three groups: Those treated with vehicle, those treated with klotho protein and those treated with klotho plus 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD). Rats without adriamycin treatment were used as a control. Results: Adriamycin reduced the serum klotho concentration and renal expression of klotho and E-cadherin. Adriamycin also increased the renal expression of Wnt, TGF-β, and angiotensinogen, as well as the renal abundance of b-catenin and angiotensin II. Klotho supplementation suppressed adriamycininduced elevations of b-catenin and angiotensin II with sustained Wnt expression. Combined treatment with klotho and TDZD reversed the klotho-induced improvements in the renal abundance of b-catenin and angiotensin II as well as the expression of TGF-β and angiotensinogen without affecting Ecadherin. Conclusions: Our data indicate that Wnt is involved in the pathogenesis of adriamycin nephropathy. Furthermore, klotho supplementation inhibited Wnt signaling, ameliorating renal angiotensin II. Finally, klotho protein appears to suppress epithelial- mesenchymal transition by inhibiting TGF-β and Wnt signaling.

KW - b-catenin

KW - fibrosis

KW - nephrin

KW - oxidative stress

KW - TRPC6

UR - http://www.scopus.com/inward/record.url?scp=85020179134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020179134&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfw340

DO - 10.1093/ndt/gfw340

M3 - Article

VL - 32

SP - 791

EP - 800

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 5

ER -